HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

BACKGROUND: Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as presenting a high or low risk for epithelial ovarian cancer (EOC). We validated this algorithm in an independent prospective study. M...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Van Gorp, T, Cadron, I, Despierre, E, Daemen, A, Leunen, K, Amant, F, Timmerman, D, De Moor, B, Vergote, I
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2011
Sujets:
Molecular Diagnostics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3048204/
https://ncbi.nlm.nih.gov/pubmed/21304524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6606092
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires